评估临床指南的成本控制潜力

{"title":"评估临床指南的成本控制潜力","authors":"Caryl E. Carpenter PhD, David B. Nash MD, MBA, Nelda E. Johnson PharmD (Project Director)","doi":"10.1016/S0097-5990(16)30604-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":76392,"journal":{"name":"QRB. Quality review bulletin","volume":"19 4","pages":"Pages 119-123"},"PeriodicalIF":0.0000,"publicationDate":"1993-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0097-5990(16)30604-2","citationCount":"11","resultStr":"{\"title\":\"Evaluating the Cost Containment Potential of Clinical Guidelines\",\"authors\":\"Caryl E. Carpenter PhD, David B. Nash MD, MBA, Nelda E. Johnson PharmD (Project Director)\",\"doi\":\"10.1016/S0097-5990(16)30604-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":76392,\"journal\":{\"name\":\"QRB. Quality review bulletin\",\"volume\":\"19 4\",\"pages\":\"Pages 119-123\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1993-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0097-5990(16)30604-2\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"QRB. Quality review bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0097599016306042\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"QRB. Quality review bulletin","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0097599016306042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}